Veristat’s Post

The Federal Council/Bundeskanzlei BK adopted the One Health Action Plan of the Swiss Antibiotic Resistance Strategy (StAR). The plan, which runs from 2024 to 2027, aims to deliver three key outcomes: 🔸 More compliance with existing guidelines and guidances against antimicrobial resistance 🔸 Boosting the use of scientific findings and technologies through specific incentives and data monitoring upgrades 🔸 Securing the existing structure and processes against antimicrobial resistance on the long run 🔗https://hubs.li/Q02DNf-X0 #antimicrobial #antimicrobialresistance #AMR

#AntimicrobialResistance can develop with remarkable speed. In 2019, 1.27 million deaths globally were caused by infections resistant to antibiotics.    The UK Government has announced a new 5-year national action plan to combat this silent pandemic, a global issue that makes infections difficult or impossible to treat. The plan will build on progress towards the UK’s 20-year vision for antimicrobial resistance (AMR), which will see AMR contained, controlled and mitigated.    In 2022, the UK invested £210 million to partner with countries across Asia and Africa to tackle AMR through the Fleming Fund. 

We welcome the National Action Plan for antimicrobial resistance (AMR) launched today by the Department of Health and Social Care. AMR is a large, complex problem that can’t be tackled by solely developing more antibiotics. Which is why through our continued investments we’re committed to supporting research across disciplines that looks at all aspects of the problem – from human behaviour and how we grow crops and rear animals for consumption, to how we manage the environment or use technology, clinical management strategies or challenge established cultural norms. This new national action plan will ensure the UK better restricts its use of antibiotics, antifungals, and antivirals – in both humans and animals – identify drug resistant infections before they emerge, and support industry in developing the next generation of treatments. Read the action plan ➡ https://lnkd.in/e9Xj6NxM

🔵 Responding to today’s launch of the UK’s next five-year national action plan for antimicrobial resistance (AMR) 2024-2029, Dr Beverley Isherwood and Dr Clive Mason, PACE Programme Directors, said: 💬 “This announcement shines a light on the urgent needs around AMR. PACE was delighted to contribute to this policy paper, and we’re pleased to see the government’s commitment to optimising antimicrobials, overcoming barriers and investing in innovation. We are dedicated to funding and supporting the innovative scientific research being conducted globally to develop diagnostics, antimicrobials and alternative therapies which meet UK and global needs. The ability to sustain and grow our capabilities and skills to address AMR is critical. PACE will continue to support this vision.”    ▶ Read more about PACE in Theme 3 – Investing in innovation, supply and access in section ‘Commitment 6.3 – Overcoming market barriers’.  ▶ This five-year national action plan supports the UK 20-year vision for antimicrobial resistance. (🔗 https://lnkd.in/gDDPWf4g)

Did you miss our last insightful webinar on the future of Antimicrobial Resistance (AMR) with Oluwatosin Akinwotu? No worries! You can catch up and gain valuable knowledge by watching the recording on our YouTube channel. Watch it here: https://lnkd.in/dPVxtjWr Kindly subscribe to our channel for more informative content and stay informed about the latest advancements in healthcare and science. Let’s combat AMR together! #amr #antimicrobialresistance

Really pleasing to see the Confronting antimicrobial resistance 2024 to 2029 plan to tackle antimicrobial resistance published by the Department of Health and Social Care yesterday. Outcome 1 of theme 1 advocates a focus on infection prevention and control and infection management. Commitment 1.1 ‘Informed interventions’ states ‘we will continue to improve IPC and biosecurity practices that are informed by the latest evidence base and social sciences to minimise the potential for infection transmission, including outbreaks, optimise the management of infections and reduce the need for antimicrobial exposure.’ We couldn’t agree more! The Proxximos digital contact tracing solution is designed to provide evidence based reduction in infection transmission. 

Monitoring antimicrobial resistance in the environment can promote healthier ecosystems & communities. Join Dr. Muziasari Friday, September 8 at 11:30 am at the World AMR Congress to learn how. Details: https://ow.ly/el3p50PFIcc

Antimicrobial Resistance (AMR) is a serious threat to global public health. The UK government has recently announced a new action plan to combat AMR, which includes support for industries to develop new treatments. I believe that a similar action plan is needed in India. AMR is a major problem in India, and it is essential that we take steps to address it. The Indian government should provide support to industries for the development of new treatments and diagnostics for AMR. This could include financial incentives, such as tax breaks or grants, as well as regulatory support, such as fast-tracking the approval process for new drugs/diagnostics. Organisations like Biotechnology Industry Research Assistance Council (BIRAC) are already doing it, but more is needed. The government and industries should also work to raise awareness of AMR among the public and healthcare professionals. This could be done through public health campaigns and educational programs. #publichealth #amr #policy Module Innovations

For those in my network concerned about antimicrobial resistance, the DHSC has just published the Confronting antimicrobial resistance 2024 to 2029 plan. This advocates a focus on infection prevention & control and seeks evidence based reductions in infection transmission. We agree & the Proxximos digital contact tracing solution supports this plan & strategy in so many ways.....

🌟 ICYMI | Transformative approaches to combat antimicrobial resistance 🌟 This joint webinar was hosted by the AMR DECLARATION TRUST and the Alliance for the Prudent Use of Antibiotics (APUA) in 2023. Antimicrobial resistance (AMR) remains one of the most pressing global health challenges of our time. As we navigate the complex landscape of modern medicine, the dual threats of antibiotic overuse in certain regions and lack of access in others present an intricate puzzle. These challenges, exacerbated by evolving global health crises like the COVID-19 pandemic, require transformative approaches. The aim of this webinar was to delve deep into the multifaceted issues surrounding AMR. Drawing from expertise across different regions and specialties, experts explored strategies ranging from grassroots implementation to high-level policy changes. https://lnkd.in/eBDEv3xD #Antimicrobialresistance #antibioticresistance #antimicrobialstewardship #publichealth #globalhealth #healthcare #infectiousdiseases #antibiotics #antimicrobials